Varian, Inc.
Palo Alto, CA 94304
Varian Installs Cyclotron for ProBeam Compact Proton Therapy System at Treatment Center in Florida
PALO ALTO, Calif., Sept. 4, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced the installation of the cyclotron for the Varian ProBeam® Compact single-room proton therapy system at the cancer treatment center on the campus of the Delray Medical Center in Delray Beach, Florida. The cyclotron is a core piece of equipment of the ProBeam proton therapy system, and its installation is a key...
Read More »
Varian Installs ProBeam Cyclotron at UCLH Proton Beam Therapy Center
PALO ALTO, Calif., June 19, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced the installation of a Varian ProBeam® cyclotron at the proton beam therapy center at University College Hospitals London NHS Foundation Trust (UCLH) in London, England. The cyclotron is a core piece of equipment of the ProBeam proton therapy system, and its installation is a key milestone for every new proton...
Read More »
Varian Calypso Anchored Beacon Transponder for Lung Receives FDA 510k Clearance
PALO ALTO, Calif., April 20, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Calypso® Anchored Beacon® transponder. Used with a Varian TrueBeam®, Edge® and Clinac® C-series medical linear accelerators, the Calypso system and Anchored Beacon transponder detects even slight movements of a tumor and helps clinicians deliver lung...
Read More »
Varian to Showcase Software Solutions for Smarter Cancer Care at HIMSS18
PALO ALTO, Calif., Feb. 26, 2018 - Varian (NYSE: VAR) today announced it will be demonstrating its portfolio of software solutions for smarter cancer care, March 5-8 in Las Vegas, NV at HIMSS18, booth 10518. Varian provides a comprehensive oncology software platform to help manage the entire cancer care process, from diagnosis to survivorship. The Varian solutions being demonstrated at HIMSS18...
Read More »Varian ARIA Oncology Information System Earns ONC Health IT Certification from Drummond Group LLC
PALO ALTO, Calif., Feb. 22, 2018 - Varian (NYSE: VAR) today announced its ARIA® oncology information system has achieved Office of the National Coordinator for Health Information Technology (ONC-Health IT) 2015 Edition Health IT Module Certification via Drummond Group LLC, an Authorized Certification Body (ACB) that has been empowered to test software for compliance with the requirements of the...
Read More »
Varian Halcyon Treatment System Receives AERB Certificate for Import & Supply in India
PALO ALTO, Calif. and MUMBAI, India - Feb. 6, 2018 - Varian (NYSE: VAR) today announced the Halcyon™ cancer treatment platform has received Atomic Energy Regulatory Board (AERB) Certificate for Import and Supply in India. This registration allows Varian to now market this new system in India. Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated...
Read More »
Varian Selected to Provide Compact Single-room System for First Proton Therapy Center in Alabama
PALO ALTO, Calif., Jan. 24, 2018 - Varian (NYSE: VAR) today announced it has been selected by Proton International to install a Varian ProBeam® Compact single-room proton therapy system in the new University of Alabama at Birmingham Proton Therapy Center. Construction on the new center is expected to begin at the end of January 2018, and first patient treatments are expected to start in early...
Read More »
Varian Halcyon Treatment System Receives Taiwan FDA Approval
PALO ALTO, Calif., Jan. 8, 2018 - Varian (NYSE: VAR) today announced its Halcyon™ system has received Taiwan FDA approval, which allows the company to market this new cancer treatment system in Taiwan. This approval further expands the global availability of Halcyon and high-quality, cost-effective cancer treatments. As an advanced cancer treatment system with a human-centered and user-friendly...
Read More »Dissolution Apparatus supports manual and automated testing.
Designed for testing tablets, capsules, and other dosage forms, Model 708-DS features traditional water bath and TruAlign(TM) vessels. System supports several automation options, including automated media temperature sensing, dosage delivery, and sampling. Integration with Varian UV or LC Dissolution Systems accelerates sample analysis, while minimizing potential for sample handling errors.
Read More »Pre-Assembled Cartridges speed oligonucleotide synthesis.
StratoSpheres(TM) DNA Synthesis Cartridges produce small to medium sized oligonucleotide strands required for use in DNA amplification, sequencing, and hybridization. Polystyrene packing provides high-throughput synthesis capabilities, while hydrophobic nature promotes production efficiency by maximizing yield of full length product. Two synthesis scales, 40 and 200 nmol, enable biochemists to...
Read More »Varian Acquisition of Noona Healthcare
Varian has acquired Noona™ Healthcare, a Helsinki-based software developer of a cloud-based, mobile service designed to capture cancer patient-reported outcomes (PROs). PROs represent a growing and significant metric in evidence-based clinical care and translational research. Patients who have experienced real-world symptom monitoring have had 20% fewer emergency room visits, 30-50% fewer calls...
Read More »Varian Signs Educational Partnerships with Reliance Group in India
PALO ALTO, Calif., Oct. 4, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has signed an educational partnership with one of India's leading hospital groups to provide greater access to training in advanced radiotherapy and radiosurgery techniques. The Varian Advanced Clinical School will run courses at the Reliance Group's' Kokilaben Dhirubhai Ambani Hospital (KDAH) in...
Read More »Varian Signs Partnership Agreement with Mediheal to Support Cancer Care in Kenya
PALO ALTO, Calif. and NAIROBI, Kenya, Sept. 7, 2018 /PRNewswire/ -- Varian (NYSE: VAR) signed a partnership agreement with Mediheal Group of Hospitals to expand access to radiotherapy in Kenya. This comprehensive partnership agreement includes the supply of advanced linear accelerators to five new radiotherapy centers across Kenya, as well as service, training and research collaboration...
Read More »
Varian Installs Cyclotron for ProBeam Compact Proton Therapy System at Treatment Center in Florida
PALO ALTO, Calif., Sept. 4, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced the installation of the cyclotron for the Varian ProBeam® Compact single-room proton therapy system at the cancer treatment center on the campus of the Delray Medical Center in Delray Beach, Florida. The cyclotron is a core piece of equipment of the ProBeam proton therapy system, and its installation is a key...
Read More »Varian CEO Dow Wilson Joins USISPF Board of Directors
PALO ALTO, Calif., Aug. 21, 2018 /PRNewswire/ -- Varian's (NYSE: VAR) president and chief executive officer, Dow R. Wilson, has joined the Board of Directors of the US-India Strategic Partnership Forum (USISPF). Mr. Wilson is among a group of prominent global business leaders advising USISPF on its efforts to strengthen the strategic relationship between the U.S. and India through job...
Read More »Varian Has Acquired HumediQ Global GmbH
Varian has acquired humediQ Global GmbH, a leader in the development of advanced patient identification, accessory verification, and motion management solutions. Based in Munich Germany and with offices in Munich and the USA, humediQ specializes in the IDENTIFY patient setup and motion management system. “The IDENTIFY solution combines improved patient safety, an enhanced clinical workflow and...
Read More »
Varian Installs ProBeam Cyclotron at UCLH Proton Beam Therapy Center
PALO ALTO, Calif., June 19, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced the installation of a Varian ProBeam® cyclotron at the proton beam therapy center at University College Hospitals London NHS Foundation Trust (UCLH) in London, England. The cyclotron is a core piece of equipment of the ProBeam proton therapy system, and its installation is a key milestone for every new proton...
Read More »Varian Halcyon Systems Expand Access to Cancer Care at Three Centers in Africa
PALO ALTO, Calif., May 30, 2018 /PRNewswire/ -- Designed to expand the availability of high quality cancer care globally and help save the lives of millions more cancer patients, treatments with Varian's (NYSE: VAR) Halcyon™ system have started at three different cancer centers in northern and southern Africa. Halcyon simplifies and enhances virtually every aspect of image-guided...
Read More »Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid
PALO ALTO, Calif., May 22, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it received notice from Sirtex Medical Limited (Sirtex) on May 21, 2018 (Pacific daylight time) that the board of directors of Sirtex has now received a binding proposal (CDH Proposal) from CDH Investments, a China-based alternative asset manager, for the acquisition of all of the issued shares of Sirtex at a...
Read More »First Cancer Patients in Korea Treated with Varian HyperArc High-Definition Radiotherapy
PALO ALTO, Calif., May 16, 2018 /PRNewswire/ -- Varian (NYSE: VAR) announced two patients with brain cancer were the first patients in Korea to be treated using the company's HyperArc™ High Definition Radiotherapy (HDRT), a new type of radiosurgery treatment, at the Ajou University Hospital. HyperArc is designed to automate and simplify sophisticated treatments such as stereotactic...
Read More »